APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 17A

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Interleukin 17A Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchInterleukin 17A Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 17A Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Interleukin 17A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 17A Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 17A Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Interleukin 17A market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 17A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Interleukin 17A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Interleukin 17A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Interleukin 17A is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Interleukin 17A include Abeome Corporation, Affibody AB, Cell Medica Limited, Orega Biotech SAS, AbbVie Inc, Eli Lilly and Company, Merck KGaA, Novartis AG and Johnson & Johnson, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Interleukin 17A, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Interleukin 17A, also provides the sales of main regions and countries. Of the upcoming market potential for Interleukin 17A, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interleukin 17A sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Interleukin 17A market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Interleukin 17A sales, projected growth trends, production technology, application and end-user industry.

Interleukin 17A Segment by Company

Abeome Corporation

Affibody AB

Cell Medica Limited

Orega Biotech SAS

AbbVie Inc

Eli Lilly and Company

Merck KGaA

Novartis AG

Johnson & Johnson

Interleukin 17A Segment by Type

DLX-2882

CNTO-6785

ABY-035

Others

Interleukin 17A Segment by Application

Kidney Cancer

Chronic Pain

Liver Cancer

Others

Interleukin 17A Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 17A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 17A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 17A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Interleukin 17A in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 17A sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Interleukin 17A Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DLX-2882 Major Manufacturers Table 3. CNTO-6785 Major Manufacturers Table 4. ABY-035 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Interleukin 17A Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Kidney Cancer Major Manufacturers Table 8. Chronic Pain Major Manufacturers Table 9. Liver Cancer Major Manufacturers Table 10. Others Major Manufacturers Table 11. Interleukin 17A Industry Trends Table 12. Interleukin 17A Industry Drivers Table 13. Interleukin 17A Industry Opportunities and Challenges Table 14. Interleukin 17A Industry Restraints Table 15. Global Interleukin 17A Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Interleukin 17A Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Interleukin 17A Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Interleukin 17A Revenue Market Share by Region (2021-2026) Table 19. Global Interleukin 17A Revenue Market Share by Region (2027-2032) Table 20. Global Interleukin 17A Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Interleukin 17A Sales by Region (2021-2026) & (W Units) Table 22. Global Interleukin 17A Sales by Region (2027-2032) & (W Units) Table 23. Global Interleukin 17A Sales Market Share by Region (2021-2026) Table 24. Global Interleukin 17A Sales Market Share by Region (2027-2032) Table 25. Global Interleukin 17A Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Interleukin 17A Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Interleukin 17A Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Interleukin 17A Sales Market Share by Manufacturers (2021-2026) Table 29. Global Interleukin 17A Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Interleukin 17A Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Interleukin 17A Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Interleukin 17A Manufacturers, Product Type & Application Table 33. Global Interleukin 17A Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Interleukin 17A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Interleukin 17A Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Interleukin 17A Revenue Market Share by Type (2021-2026) Table 40. Global Interleukin 17A Revenue Market Share by Type (2027-2032) Table 41. Global Interleukin 17A Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 43. Global Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 44. Global Interleukin 17A Sales Market Share by Type (2021-2026) Table 45. Global Interleukin 17A Sales Market Share by Type (2027-2032) Table 46. Global Interleukin 17A Price by Type (2021-2026) & (US$/Unit) Table 47. Global Interleukin 17A Price by Type (2027-2032) & (US$/Unit) Table 48. Global Interleukin 17A Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Interleukin 17A Revenue Market Share by Application (2021-2026) Table 52. Global Interleukin 17A Revenue Market Share by Application (2027-2032) Table 53. Global Interleukin 17A Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 55. Global Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 56. Global Interleukin 17A Sales Market Share by Application (2021-2026) Table 57. Global Interleukin 17A Sales Market Share by Application (2027-2032) Table 58. Global Interleukin 17A Price by Application (2021-2026) & (US$/Unit) Table 59. Global Interleukin 17A Price by Application (2027-2032) & (US$/Unit) Table 60. Abeome Corporation Company Information Table 61. Abeome Corporation Business Overview Table 62. Abeome Corporation Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Abeome Corporation Interleukin 17A Product Portfolio Table 64. Abeome Corporation Recent Development Table 65. Affibody AB Company Information Table 66. Affibody AB Business Overview Table 67. Affibody AB Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Affibody AB Interleukin 17A Product Portfolio Table 69. Affibody AB Recent Development Table 70. Cell Medica Limited Company Information Table 71. Cell Medica Limited Business Overview Table 72. Cell Medica Limited Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Cell Medica Limited Interleukin 17A Product Portfolio Table 74. Cell Medica Limited Recent Development Table 75. Orega Biotech SAS Company Information Table 76. Orega Biotech SAS Business Overview Table 77. Orega Biotech SAS Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Orega Biotech SAS Interleukin 17A Product Portfolio Table 79. Orega Biotech SAS Recent Development Table 80. AbbVie Inc Company Information Table 81. AbbVie Inc Business Overview Table 82. AbbVie Inc Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. AbbVie Inc Interleukin 17A Product Portfolio Table 84. AbbVie Inc Recent Development Table 85. Eli Lilly and Company Company Information Table 86. Eli Lilly and Company Business Overview Table 87. Eli Lilly and Company Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Eli Lilly and Company Interleukin 17A Product Portfolio Table 89. Eli Lilly and Company Recent Development Table 90. Merck KGaA Company Information Table 91. Merck KGaA Business Overview Table 92. Merck KGaA Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Merck KGaA Interleukin 17A Product Portfolio Table 94. Merck KGaA Recent Development Table 95. Novartis AG Company Information Table 96. Novartis AG Business Overview Table 97. Novartis AG Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Novartis AG Interleukin 17A Product Portfolio Table 99. Novartis AG Recent Development Table 100. Johnson & Johnson Company Information Table 101. Johnson & Johnson Business Overview Table 102. Johnson & Johnson Interleukin 17A Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Johnson & Johnson Interleukin 17A Product Portfolio Table 104. Johnson & Johnson Recent Development Table 105. North America Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 108. North America Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 109. North America Interleukin 17A Sales Price by Type (2021-2026) & (US$/Unit) Table 110. North America Interleukin 17A Sales Price by Type (2027-2032) & (US$/Unit) Table 111. North America Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 114. North America Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 115. North America Interleukin 17A Sales Price by Application (2021-2026) & (US$/Unit) Table 116. North America Interleukin 17A Sales Price by Application (2027-2032) & (US$/Unit) Table 117. North America Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. North America Interleukin 17A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. North America Interleukin 17A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. North America Interleukin 17A Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 121. North America Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 122. North America Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 123. North America Interleukin 17A Sales Price by Country (2021-2026) & (US$/Unit) Table 124. North America Interleukin 17A Sales Price by Country (2027-2032) & (US$/Unit) Table 125. United States Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 126. Canada Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 127. Mexico Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 128. Europe Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 131. Europe Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 132. Europe Interleukin 17A Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Interleukin 17A Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 137. Europe Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 138. Europe Interleukin 17A Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Interleukin 17A Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Interleukin 17A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Interleukin 17A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Interleukin 17A Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 144. Europe Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 145. Europe Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 146. Europe Interleukin 17A Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Interleukin 17A Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 149. France Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 150. U.K. Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 151. Italy Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 152. Russia Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 153. Spain Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 155. Switzerland Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 156. Sweden Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 157. Poland Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 158. China Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 159. China Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 160. China Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 161. China Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 162. China Interleukin 17A Sales Price by Type (2021-2026) & (US$/Unit) Table 163. China Interleukin 17A Sales Price by Type (2027-2032) & (US$/Unit) Table 164. China Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 165. China Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 166. China Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 167. China Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 168. China Interleukin 17A Sales Price by Application (2021-2026) & (US$/Unit) Table 169. China Interleukin 17A Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 171. Asia Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 172. Asia Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 173. Asia Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 174. Asia Interleukin 17A Sales Price by Type (2021-2026) & (US$/Unit) Table 175. Asia Interleukin 17A Sales Price by Type (2027-2032) & (US$/Unit) Table 176. Asia Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 177. Asia Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 178. Asia Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 179. Asia Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 180. Asia Interleukin 17A Sales Price by Application (2021-2026) & (US$/Unit) Table 181. Asia Interleukin 17A Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 183. Asia Interleukin 17A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 184. Asia Interleukin 17A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 185. Asia Interleukin 17A Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 186. Asia Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 187. Asia Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 188. Asia Interleukin 17A Sales Price by Country (2021-2026) & (US$/Unit) Table 189. Asia Interleukin 17A Sales Price by Country (2027-2032) & (US$/Unit) Table 190. Japan Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 191. South Korea Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 192. India Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 193. Australia Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 194. Taiwan Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 195. Southeast Asia Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 196. SAMEA Interleukin 17A Revenue by Type (2021-2026) & (US$ Million) Table 197. SAMEA Interleukin 17A Revenue by Type (2027-2032) & (US$ Million) Table 198. SAMEA Interleukin 17A Sales by Type (2021-2026) & (W Units) Table 199. SAMEA Interleukin 17A Sales by Type (2027-2032) & (W Units) Table 200. SAMEA Interleukin 17A Sales Price by Type (2021-2026) & (US$/Unit) Table 201. SAMEA Interleukin 17A Sales Price by Type (2027-2032) & (US$/Unit) Table 202. SAMEA Interleukin 17A Revenue by Application (2021-2026) & (US$ Million) Table 203. SAMEA Interleukin 17A Revenue by Application (2027-2032) & (US$ Million) Table 204. SAMEA Interleukin 17A Sales by Application (2021-2026) & (W Units) Table 205. SAMEA Interleukin 17A Sales by Application (2027-2032) & (W Units) Table 206. SAMEA Interleukin 17A Sales Price by Application (2021-2026) & (US$/Unit) Table 207. SAMEA Interleukin 17A Sales Price by Application (2027-2032) & (US$/Unit) Table 208. SAMEA Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. SAMEA Interleukin 17A Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. SAMEA Interleukin 17A Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. SAMEA Interleukin 17A Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 212. SAMEA Interleukin 17A Sales by Country (2021-2026) & (W Units) Table 213. SAMEA Interleukin 17A Sales by Country (2027-2032) & (W Units) Table 214. SAMEA Interleukin 17A Sales Price by Country (2021-2026) & (US$/Unit) Table 215. SAMEA Interleukin 17A Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Brazil Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 217. Argentina Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 218. Chile Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 219. Colombia Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 220. Peru Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 221. Saudi Arabia Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 222. Israel Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 223. UAE Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 224. Turkey Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 225. Iran Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 226. Egypt Interleukin 17A Revenue (2021-2032) & (US$ Million) Table 227. Key Raw Materials Table 228. Raw Materials Key Suppliers Table 229. Interleukin 17A Distributors List Table 230. Interleukin 17A Customers List Table 231. Research Programs/Design for This Report Table 232. Authors List of This Report Table 233. Secondary Sources Table 234. Primary Sources List of Figures Figure 1. Interleukin 17A Image Figure 2. Global Interleukin 17A Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 17A Market Size Share 2021 VS 2025 VS 2032 Figure 4. DLX-2882 Image Figure 5. CNTO-6785 Image Figure 6. ABY-035 Image Figure 7. Others Image Figure 8. Global Interleukin 17A Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Interleukin 17A Market Size Share 2021 VS 2025 VS 2032 Figure 10. Kidney Cancer Image Figure 11. Chronic Pain Image Figure 12. Liver Cancer Image Figure 13. Others Image Figure 14. Global Interleukin 17A Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Interleukin 17A Revenue (2021-2032) & (US$ Million) Figure 16. Global Interleukin 17A Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Interleukin 17A Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Interleukin 17A Revenue Market Share by Region (2021-2032) Figure 19. Global Interleukin 17A Sales (2021-2032) & (W Units) Figure 20. Global Interleukin 17A Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Interleukin 17A Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Interleukin 17A Sales YoY (2021-2032) & (W Units) Figure 23. Europe Interleukin 17A Sales YoY (2021-2032) & (W Units) Figure 24. China Interleukin 17A Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Interleukin 17A Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Interleukin 17A Sales YoY (2021-2032) & (W Units) Figure 27. Global Interleukin 17A Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Interleukin 17A Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Interleukin 17A Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Interleukin 17A Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Interleukin 17A Revenue Market Share by Type (2021-2032) Figure 33. Global Interleukin 17A Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Interleukin 17A Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Interleukin 17A Sales Market Share by Type (2021-2032) Figure 36. Global Interleukin 17A Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Interleukin 17A Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Interleukin 17A Revenue Market Share by Application (2021-2032) Figure 39. Global Interleukin 17A Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Interleukin 17A Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Interleukin 17A Sales Market Share by Application (2021-2032) Figure 42. North America Interleukin 17A Revenue Share by Type (2021-2032) Figure 43. North America Interleukin 17A Sales Share by Type (2021-2032) Figure 44. North America Interleukin 17A Revenue Share by Application (2021-2032) Figure 45. North America Interleukin 17A Sales Share by Application (2021-2032) Figure 46. North America Interleukin 17A Revenue Share by Country (2021-2032) Figure 47. North America Interleukin 17A Sales Share by Country (2021-2032) Figure 48. Europe Interleukin 17A Revenue Share by Type (2021-2032) Figure 49. Europe Interleukin 17A Sales Share by Type (2021-2032) Figure 50. Europe Interleukin 17A Revenue Share by Application (2021-2032) Figure 51. Europe Interleukin 17A Sales Share by Application (2021-2032) Figure 52. Europe Interleukin 17A Revenue Share by Country (2021-2032) Figure 53. Europe Interleukin 17A Sales Share by Country (2021-2032) Figure 54. China Interleukin 17A Revenue Share by Type (2021-2032) Figure 55. China Interleukin 17A Sales Share by Type (2021-2032) Figure 56. China Interleukin 17A Revenue Share by Application (2021-2032) Figure 57. China Interleukin 17A Sales Share by Application (2021-2032) Figure 58. Asia Interleukin 17A Revenue Share by Type (2021-2032) Figure 59. Asia Interleukin 17A Sales Share by Type (2021-2032) Figure 60. Asia Interleukin 17A Revenue Share by Application (2021-2032) Figure 61. Asia Interleukin 17A Sales Share by Application (2021-2032) Figure 62. Asia Interleukin 17A Revenue Share by Country (2021-2032) Figure 63. Asia Interleukin 17A Sales Share by Country (2021-2032) Figure 64. SAMEA Interleukin 17A Revenue Share by Type (2021-2032) Figure 65. SAMEA Interleukin 17A Sales Share by Type (2021-2032) Figure 66. SAMEA Interleukin 17A Revenue Share by Application (2021-2032) Figure 67. SAMEA Interleukin 17A Sales Share by Application (2021-2032) Figure 68. SAMEA Interleukin 17A Revenue Share by Country (2021-2032) Figure 69. SAMEA Interleukin 17A Sales Share by Country (2021-2032) Figure 70. Interleukin 17A Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Interleukin 17A Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • DLX-2882
  • CNTO-6785
  • ABY-035
  • Others
Applications
  • Kidney Cancer
  • Chronic Pain
  • Liver Cancer
  • Others
Companies covered
  • Abeome Corporation
  • Affibody AB
  • Cell Medica Limited
  • Orega Biotech SAS
  • AbbVie Inc
  • Eli Lilly and Company
  • Merck KGaA
  • Novartis AG
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Interleukin 17A Market by Type
  3. 1.2.1 Global Interleukin 17A Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DLX-2882
  5. 1.2.3 CNTO-6785
  6. 1.2.4 ABY-035
  7. 1.2.5 Others
  8. 1.3 Interleukin 17A Market by Application
  9. 1.3.1 Global Interleukin 17A Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Kidney Cancer
  11. 1.3.3 Chronic Pain
  12. 1.3.4 Liver Cancer
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Interleukin 17A Market Dynamics
  1. 2.1 Interleukin 17A Industry Trends
  2. 2.2 Interleukin 17A Industry Drivers
  3. 2.3 Interleukin 17A Industry Opportunities and Challenges
  4. 2.4 Interleukin 17A Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Interleukin 17A Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Interleukin 17A Revenue by Region
  3. 3.2.1 Global Interleukin 17A Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Interleukin 17A Revenue by Region (2021-2026)
  5. 3.2.3 Global Interleukin 17A Revenue by Region (2027-2032)
  6. 3.2.4 Global Interleukin 17A Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Interleukin 17A Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Interleukin 17A Sales by Region
  9. 3.4.1 Global Interleukin 17A Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Interleukin 17A Sales by Region (2021-2026)
  11. 3.4.3 Global Interleukin 17A Sales by Region (2027-2032)
  12. 3.4.4 Global Interleukin 17A Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Interleukin 17A Revenue by Manufacturers
  2. 4.1.1 Global Interleukin 17A Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Interleukin 17A Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Interleukin 17A Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Interleukin 17A Sales by Manufacturers
  6. 4.2.1 Global Interleukin 17A Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Interleukin 17A Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Interleukin 17A Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Interleukin 17A Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Interleukin 17A Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Interleukin 17A Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Interleukin 17A Manufacturers, Product Type & Application
  13. 4.7 Global Interleukin 17A Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Interleukin 17A Market CR5 and HHI
  16. 4.8.2 2025 Interleukin 17A Tier 1, Tier 2, and Tier 3
5 Interleukin 17A Market by Type
  1. 5.1 Global Interleukin 17A Revenue by Type
  2. 5.1.1 Global Interleukin 17A Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Interleukin 17A Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Interleukin 17A Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Interleukin 17A Sales by Type
  6. 5.2.1 Global Interleukin 17A Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Interleukin 17A Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Interleukin 17A Sales Market Share by Type (2021-2032)
  9. 5.3 Global Interleukin 17A Price by Type
6 Interleukin 17A Market by Application
  1. 6.1 Global Interleukin 17A Revenue by Application
  2. 6.1.1 Global Interleukin 17A Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Interleukin 17A Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Interleukin 17A Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Interleukin 17A Sales by Application
  6. 6.2.1 Global Interleukin 17A Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Interleukin 17A Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Interleukin 17A Sales Market Share by Application (2021-2032)
  9. 6.3 Global Interleukin 17A Price by Application
7 Company Profiles
  1. 7.1 Abeome Corporation
  2. 7.1.1 Abeome Corporation Company Information
  3. 7.1.2 Abeome Corporation Business Overview
  4. 7.1.3 Abeome Corporation Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abeome Corporation Interleukin 17A Product Portfolio
  6. 7.1.5 Abeome Corporation Recent Developments
  7. 7.2 Affibody AB
  8. 7.2.1 Affibody AB Company Information
  9. 7.2.2 Affibody AB Business Overview
  10. 7.2.3 Affibody AB Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Affibody AB Interleukin 17A Product Portfolio
  12. 7.2.5 Affibody AB Recent Developments
  13. 7.3 Cell Medica Limited
  14. 7.3.1 Cell Medica Limited Company Information
  15. 7.3.2 Cell Medica Limited Business Overview
  16. 7.3.3 Cell Medica Limited Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Cell Medica Limited Interleukin 17A Product Portfolio
  18. 7.3.5 Cell Medica Limited Recent Developments
  19. 7.4 Orega Biotech SAS
  20. 7.4.1 Orega Biotech SAS Company Information
  21. 7.4.2 Orega Biotech SAS Business Overview
  22. 7.4.3 Orega Biotech SAS Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Orega Biotech SAS Interleukin 17A Product Portfolio
  24. 7.4.5 Orega Biotech SAS Recent Developments
  25. 7.5 AbbVie Inc
  26. 7.5.1 AbbVie Inc Company Information
  27. 7.5.2 AbbVie Inc Business Overview
  28. 7.5.3 AbbVie Inc Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AbbVie Inc Interleukin 17A Product Portfolio
  30. 7.5.5 AbbVie Inc Recent Developments
  31. 7.6 Eli Lilly and Company
  32. 7.6.1 Eli Lilly and Company Company Information
  33. 7.6.2 Eli Lilly and Company Business Overview
  34. 7.6.3 Eli Lilly and Company Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly and Company Interleukin 17A Product Portfolio
  36. 7.6.5 Eli Lilly and Company Recent Developments
  37. 7.7 Merck KGaA
  38. 7.7.1 Merck KGaA Company Information
  39. 7.7.2 Merck KGaA Business Overview
  40. 7.7.3 Merck KGaA Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Merck KGaA Interleukin 17A Product Portfolio
  42. 7.7.5 Merck KGaA Recent Developments
  43. 7.8 Novartis AG
  44. 7.8.1 Novartis AG Company Information
  45. 7.8.2 Novartis AG Business Overview
  46. 7.8.3 Novartis AG Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis AG Interleukin 17A Product Portfolio
  48. 7.8.5 Novartis AG Recent Developments
  49. 7.9 Johnson & Johnson
  50. 7.9.1 Johnson & Johnson Company Information
  51. 7.9.2 Johnson & Johnson Business Overview
  52. 7.9.3 Johnson & Johnson Interleukin 17A Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Johnson & Johnson Interleukin 17A Product Portfolio
  54. 7.9.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Interleukin 17A Market Size by Type
  2. 8.1.1 North America Interleukin 17A Revenue by Type (2021-2032)
  3. 8.1.2 North America Interleukin 17A Sales by Type (2021-2032)
  4. 8.1.3 North America Interleukin 17A Price by Type (2021-2032)
  5. 8.2 North America Interleukin 17A Market Size by Application
  6. 8.2.1 North America Interleukin 17A Revenue by Application (2021-2032)
  7. 8.2.2 North America Interleukin 17A Sales by Application (2021-2032)
  8. 8.2.3 North America Interleukin 17A Price by Application (2021-2032)
  9. 8.3 North America Interleukin 17A Market Size by Country
  10. 8.3.1 North America Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Interleukin 17A Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Interleukin 17A Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Interleukin 17A Market Size by Type
  2. 9.1.1 Europe Interleukin 17A Revenue by Type (2021-2032)
  3. 9.1.2 Europe Interleukin 17A Sales by Type (2021-2032)
  4. 9.1.3 Europe Interleukin 17A Price by Type (2021-2032)
  5. 9.2 Europe Interleukin 17A Market Size by Application
  6. 9.2.1 Europe Interleukin 17A Revenue by Application (2021-2032)
  7. 9.2.2 Europe Interleukin 17A Sales by Application (2021-2032)
  8. 9.2.3 Europe Interleukin 17A Price by Application (2021-2032)
  9. 9.3 Europe Interleukin 17A Market Size by Country
  10. 9.3.1 Europe Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Interleukin 17A Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Interleukin 17A Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Interleukin 17A Market Size by Type
  2. 10.1.1 China Interleukin 17A Revenue by Type (2021-2032)
  3. 10.1.2 China Interleukin 17A Sales by Type (2021-2032)
  4. 10.1.3 China Interleukin 17A Price by Type (2021-2032)
  5. 10.2 China Interleukin 17A Market Size by Application
  6. 10.2.1 China Interleukin 17A Revenue by Application (2021-2032)
  7. 10.2.2 China Interleukin 17A Sales by Application (2021-2032)
  8. 10.2.3 China Interleukin 17A Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Interleukin 17A Market Size by Type
  2. 11.1.1 Asia Interleukin 17A Revenue by Type (2021-2032)
  3. 11.1.2 Asia Interleukin 17A Sales by Type (2021-2032)
  4. 11.1.3 Asia Interleukin 17A Price by Type (2021-2032)
  5. 11.2 Asia Interleukin 17A Market Size by Application
  6. 11.2.1 Asia Interleukin 17A Revenue by Application (2021-2032)
  7. 11.2.2 Asia Interleukin 17A Sales by Application (2021-2032)
  8. 11.2.3 Asia Interleukin 17A Price by Application (2021-2032)
  9. 11.3 Asia Interleukin 17A Market Size by Country
  10. 11.3.1 Asia Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Interleukin 17A Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Interleukin 17A Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Interleukin 17A Market Size by Type
  2. 12.1.1 SAMEA Interleukin 17A Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Interleukin 17A Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Interleukin 17A Price by Type (2021-2032)
  5. 12.2 SAMEA Interleukin 17A Market Size by Application
  6. 12.2.1 SAMEA Interleukin 17A Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Interleukin 17A Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Interleukin 17A Price by Application (2021-2032)
  9. 12.3 SAMEA Interleukin 17A Market Size by Country
  10. 12.3.1 SAMEA Interleukin 17A Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Interleukin 17A Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Interleukin 17A Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Interleukin 17A Value Chain Analysis
  2. 13.1.1 Interleukin 17A Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Interleukin 17A Production Mode & Process
  6. 13.2 Interleukin 17A Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Interleukin 17A Distributors
  9. 13.2.3 Interleukin 17A Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst